B. Fendly

发表

Differential responses of human tumor cell lines to anti-p185HER2 monoclonal antibodies

P. Carter, H. Shepard, I. Figari, 1993, Cancer Immunology, Immunotherapy.

p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor

A. Ullrich, M. Winget, H. Shepard, 1989, Molecular and cellular biology.

Humanization of an antibody directed against IgE.

L. Presta, C. Gorman, B. Fendly, 1993, Journal of immunology.

Generation of antibodies and assays for transforming growth factor beta.

V. Mukku, M. Palladino, B. Fendly, 1991, Methods in enzymology.

Inhibition of allergic reactions with antibodies to IgE.

L. Presta, Ricardo Saban, B. Fendly, 1995, International archives of allergy and immunology.

p 185 HER 2 Monoclonal Antibody Has An ( iproliferative Effects In Vitro and Sensitizes Human Breast Tumor Cells to Tumor Necrosis Factor

M. Winget, H. Shepard, G. Lewis, 2022 .

The autocrine production of transforming growth factor-beta 1 during lymphocyte activation. A study with a monoclonal antibody-based ELISA.

I. Figari, M. Palladino, B. Fendly, 1990, Journal of immunology.

MONOCLONAL ANTI-HLA-B27 ANTIBODY (B27M1): PRODUCTION AND LACK OF DETECTABLE TYPING DIFFERENCE BETWEEN PATIENTS WITH ANKYLOSING SPONDYLITIS, REITER'S SYNDROME, AND NORMAL CONTROLS

F. Grumet, B. Fendly, E. Engleman, 1981, The Lancet.

Evidence for an autocrine role of activin B within rat anterior pituitary cultures.

A. Mason, R. Carroll, R. Schwall, 1991, Endocrinology.

Mammalian cell transient expression of tissue factor for the production of antigen.

R. Lawn, G. Vehar, B. Fendly, 1990, Protein engineering.

Monoclonal antibody (B27M2) subdividing HLA-B27.

E. Engleman, S. Foung, F. Grumet, 1982, Human immunology.

HLA-DR epitope region definition by use of monoclonal antibody probes.

D. Charron, F. Grumet, B. Fendly, 1980, Journal of immunology.

A monoclonal-antibody-based enzyme-linked immunosorbent assay of lipoprotein(a).

P. Hass, B. Fendly, D. Eaton, 1990, Clinical chemistry.

Anti-IgE monoclonal antibodies that inhibit allergen-specific histamine release.

L. Presta, W. Werther, B. Fendly, 1995, International archives of allergy and immunology.

Protein A binding assay for the identification of HLA antigens on peripheral blood lymphocytes by monoclonal antibodies: application to HLA B27.

E. Engleman, J. Shively, F. Grumet, 1982, Hybridoma.

Novel Non-isotopic Method for the Localization of Receptors in Tissue Sections

R. Vandlen, B. Fendly, L. Desnoyers, 2001, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Characterization of murine monoclonal antibodies that recognize neutralizing epitopes on human C5a

J. Larrick, S. Kunkel, B. Fendly, 1987, Infection and immunity.

A simplified new method for HLA-DR typing using the TM1 monoclonal antibody.

E. Engleman, F. Grumet, B. Fendly, 1983, Human immunology.

Monoclonal antibody based ELISAs for measurement of activins in biological fluids.

J. Lofgren, W. L. Wong, T. Woodruff, 1993, Journal of immunological methods.

Prevention of the graft-versus-host reaction in newborn mice by antibodies to tumor necrosis factor-alpha.

R. Schreiber, A. Ammann, M. Shalaby, 1989, Transplantation.

Increase in cyclic AMP levels by relaxin in newborn rhesus monkey uterus cell culture

D. Drolet, M. Mohler, B. Fendly, 1990, In Vitro Cellular & Developmental Biology.

Strain specificity and binding affinity requirements of neutralizing monoclonal antibodies to the C4 domain of gp120 from human immunodeficiency virus type 1

G. Nakamura, P. Berman, R. Hastings, 1993, Journal of virology.

Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.

Mahlon D. Johnson, C. Arteaga, J. T. Forbes, 1993, The Journal of clinical investigation.

Natriuretic Peptide Receptor-B (Guanylyl Cyclase-B) Mediates C-type Natriuretic Peptide Relaxation of Precontracted Rat Aorta (*)

D. Garbers, B. Fendly, J. Drewett, 1995, The Journal of Biological Chemistry.

Passive immunoneutralization with a monoclonal antibody reveals a role for endogenous activin-B in mediating FSH hypersecretion during estrus and following ovariectomy of hypophysectomized, pituitary-grafted rats.

B. Fendly, L. Bald, L. Depaolo, 1992, Endocrinology.

Species-specific monoclonal antibody to a 43,000-molecular-weight membrane protein of Mycoplasma pneumoniae

S. Coates, B. Fendly, R. Madsen, 1986, Journal of clinical microbiology.

TGF-beta: a possible autocrine immune regulator.

I. Figari, M. Palladino, B. Fendly, 1991, Ciba Foundation symposium.

Vaccination with the extracellular domain of p185neu prevents mammary tumor development in neu transgenic mice

L. Esserman, M. Campbell, B. Fendly, 1999, Cancer Immunology, Immunotherapy.

Monoclonal antibody therapy of human cancer: Taking the HER2 protooncogene to the clinic

A. Ullrich, C. Kotts, H. Shepard, 1991, Journal of Clinical Immunology.

High resolution functional analysis of antibody-antigen interactions.

L. Jin, J A Wells, B. Fendly, 1992, Journal of molecular biology.

Development and characterization of murine monoclonal antibodies to the latency-associated peptide of transforming growth factor β1

B. Fendly, J. Hongo, C. Lucas, 1995 .

Mutational Analysis of Thrombopoietin for Identification of Receptor and Neutralizing Antibody Sites*

L. Presta, K. Pearce, B. Fendly, 1997, The Journal of Biological Chemistry.

Development of a specific and sensitive two-site enzyme-linked immunosorbent assay for measurement of inhibin-A in serum.

T. Woodruff, D. Allison, B. Fendly, 1993, Endocrinology.

Development and characterization of murine monoclonal antibodies to the latency-associated peptide of transforming growth factor beta 1.

B. Fendly, J. Hongo, C. Lucas, 1995, Hybridoma.

Expression of the p185 encoded by her2 oncogene in normal and transformed human tissues

A. Ullrich, D. Slamon, P. Natali, 1990, International journal of cancer.

Characterization of murine monoclonal antibodies reactive to either the human epidermal growth factor receptor or HER2/neu gene product.

A. Ullrich, M. Winget, B. Fendly, 1990, Cancer research.

Nonclinical studies addressing the mechanism of action of trastuzumab (Herceptin).

M. Sliwkowski, J. Lofgren, B. Fendly, 1999, Seminars in oncology.

Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors.

N. Goldstein, M. Hung, R. Kerbel, 1997, The American journal of pathology.

Growth regulation of human breast and ovarian tumor cells by heregulin: Evidence for the requirement of ErbB2 as a critical component in mediating heregulin responsiveness.

M. Sliwkowski, K. Bauer, J. Lofgren, 1996, Cancer research.

Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin.

M. Sliwkowski, R. Vandlen, G. Schaefer, 1994, The Journal of biological chemistry.

Stimulation of human T-cell proliferation by specific activation of the 75-kDa tumor necrosis factor receptor.

L. Tartaglia, D. Goeddel, I. Figari, 1993, Journal of immunology.

Murine tumor cells transduced with the gene for tumor necrosis factor-alpha. Evidence for paracrine immune effects of tumor necrosis factor against tumors.

A. Asher, S. Rosenberg, J. Mulé, 1991, Journal of immunology.

Characterization of a recombinant extracellular domain of the type 1 tumor necrosis factor receptor: evidence for tumor necrosis factor-alpha induced receptor aggregation.

D. Goeddel, W. Kohr, D. Pennica, 1992, Biochemistry.

Epidermal growth factor and transforming growth factor alpha bind differently to the epidermal growth factor receptor.

M. Winget, B. Fendly, B. Fendly, 1989, Biochemistry.

Activation of TNF‐R1 receptor in the presence of copper kills TNF resistant CEM leukemic T cells

H. Sussman, B. Fendly, N. Chiang, 1994, Journal of cellular physiology.

A truncated intracellular HER2/neu receptor produced by alternative RNA processing affects growth of human carcinoma cells

G. Scott, B. Fendly, J. Park, 1993, Molecular and cellular biology.

Biochemical properties of the 75-kDa tumor necrosis factor receptor. Characterization of ligand binding, internalization, and receptor phosphorylation.

D. Goeddel, D. Pennica, B. Fendly, 1992, The Journal of biological chemistry.

Generation of antibodies and assays for transforming growth factor alpha.

R. Derynck, T. Bringman, B. Fendly, 1991, Methods in enzymology.

Development of herceptin.

M. Sliwkowski, P. Carter, B. Fendly, 2000, Breast disease.